China vows to slash cancer drug prices

Jul 09, 2018

Financial Times

Chinese government officials have vowed to speed up cuts to the cost of cancer drugs in a move that threatens revenues in the country for big drugmakers such as Eli Lilly, Roche and Novartis.

According to Zhao Heng of Latitude Health, reported by the Financial Times, drugs already covered by state-insurance could have their prices cut by 10 percent, with reductions of up to 50 percent for other medications as a condition of them being added to the state insurance scheme.

Officials have also tried to push pharma companies to cut prices by threatening a switch to cheaper, local generics in state hospitals.

According to FT sources, several multinational pharma companies have been invited for talks with government officials over prices this week.

Read the FT article

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments